US NEWS and World Report
Finding also bolsters tie between vitamin D and the brain disease
HealthDay News) -- Researchers have identified nine genes that might make people more likely to develop Alzheimer's disease.
In addition, they confirmed earlier reports that a variation in the vitamin D3 receptor gene, on chromosome 12, might also increase risk for Alzheimer's. Low levels of vitamin D have been found in people with Alzheimer's and other dementias, leading researchers to suspect a link....read the whole article
Here is some addtitional information about dementia
For Alzheimer's activities suggested by an expert, click here
Susan Berg, dementia expert, shares practical help for caregivers of those with dementia including easy to do activities
Thursday, January 8, 2009
Wednesday, January 7, 2009
A protein that protects against Alzheimer's?
e! Science News
Research on the mechanisms involved in neurodegenerative diseases such as Alzheimer's, stroke, dementia, Parkinson's and multiple sclerosis, to name a few, has taken a step forward thanks to the work of biological sciences Ph.D. student Sonia Do Carmo, supervised by Professor Éric Rassart of the Université du Québec à Montreal (UQAM) Biological Sciences Department, in collaboration with researchers at the Armand-Frappier Institute and the University of Valladolid in Spain. Do Carmo and her collaborators have successfully demonstrated the protective and reparative role of apolipoprotein D, or ApoD, in neurodegenerative diseases. Their discovery suggests interesting avenues for preventing and slowing the progression of this type of illness.
These studies were inspired by work done ten years ago by Professor Rassart's team, who then discovered increased levels of ApoD in the brains of people with several types of neurodegenerative disorders, including Alzheimer's. The team hypothesized that this protein might play a protective and restorative role but were....read the whole story
Click here for more dementia information
For outstanding dementia activities, click here
Research on the mechanisms involved in neurodegenerative diseases such as Alzheimer's, stroke, dementia, Parkinson's and multiple sclerosis, to name a few, has taken a step forward thanks to the work of biological sciences Ph.D. student Sonia Do Carmo, supervised by Professor Éric Rassart of the Université du Québec à Montreal (UQAM) Biological Sciences Department, in collaboration with researchers at the Armand-Frappier Institute and the University of Valladolid in Spain. Do Carmo and her collaborators have successfully demonstrated the protective and reparative role of apolipoprotein D, or ApoD, in neurodegenerative diseases. Their discovery suggests interesting avenues for preventing and slowing the progression of this type of illness.
These studies were inspired by work done ten years ago by Professor Rassart's team, who then discovered increased levels of ApoD in the brains of people with several types of neurodegenerative disorders, including Alzheimer's. The team hypothesized that this protein might play a protective and restorative role but were....read the whole story
Click here for more dementia information
For outstanding dementia activities, click here
Tuesday, January 6, 2009
Axona, a new drug for Alzheimer's
Alzheimer's and dementia weekly
Axona is a new medical food product for the clinical dietary management of mild-to-moderate Alzheimer's Disease (AD). Axona has been shown in randomized, placebo controlled clinical trials to safely improve cognitive function and memory in patients diagnosed with mild-to-moderate AD. It will be marketed as an adjunctive therapy to currently approved AD drugs. Axona will be administered under physician supervision and dispensed by prescription, in accordance with applicable FDA regulations.
Axona provides........read the whole article
Foe more dementia information, click here
For ASlzheimer's and dementia activities, click here
Axona is a new medical food product for the clinical dietary management of mild-to-moderate Alzheimer's Disease (AD). Axona has been shown in randomized, placebo controlled clinical trials to safely improve cognitive function and memory in patients diagnosed with mild-to-moderate AD. It will be marketed as an adjunctive therapy to currently approved AD drugs. Axona will be administered under physician supervision and dispensed by prescription, in accordance with applicable FDA regulations.
Axona provides........read the whole article
Foe more dementia information, click here
For ASlzheimer's and dementia activities, click here
Monday, January 5, 2009
Good News, Bad News on Alzheimer's Prevention
Psychiatric News
Clinical & Research News
Joan Arehart-Treichel
If avoiding Alzheimer's is one of your priorities, you might consider discarding your ginkgo tablets and enrolling in a continuing medical education course.
Many Americans believe that use of the herb Ginkgo biloba can help stave off development of Alzheimer's disease. However, results from a large clinical trial are sure to disappoint ginkgo proponents.
The trial, headed by Steven DeKosky, M.D., of the University of Virginia and a leading Alzheimer's scientist, was conducted at five academic medical centers throughout the United States. It included more than 3,000 community volunteers aged 75 or older with either normal cognition or mild cognitive impairment. It used a randomized, placebo-controlled, double-blind design.
Half the subjects took 120 mg of ginkgo twice a day, and half took a placebo twice a day. Subjects were evaluated every six months for dementia over the following six years. At the end of the six years, 523 subjects had developed dementia—277 in the ginkgo group and 246 in the placebo group.
Moreover, when the researchers looked to see whether.....read the whole article
For more dementia information, click here
Amazing dementia activities can be found here
Clinical & Research News
Joan Arehart-Treichel
If avoiding Alzheimer's is one of your priorities, you might consider discarding your ginkgo tablets and enrolling in a continuing medical education course.
Many Americans believe that use of the herb Ginkgo biloba can help stave off development of Alzheimer's disease. However, results from a large clinical trial are sure to disappoint ginkgo proponents.
The trial, headed by Steven DeKosky, M.D., of the University of Virginia and a leading Alzheimer's scientist, was conducted at five academic medical centers throughout the United States. It included more than 3,000 community volunteers aged 75 or older with either normal cognition or mild cognitive impairment. It used a randomized, placebo-controlled, double-blind design.
Half the subjects took 120 mg of ginkgo twice a day, and half took a placebo twice a day. Subjects were evaluated every six months for dementia over the following six years. At the end of the six years, 523 subjects had developed dementia—277 in the ginkgo group and 246 in the placebo group.
Moreover, when the researchers looked to see whether.....read the whole article
For more dementia information, click here
Amazing dementia activities can be found here
Is Inflammation Causing Cancer, Arthritis and Alzheimer's?
PRweb
Inflammation is your immune system's way of protecting you from physical trauma or foreign invaders, such as viruses and bacteria. It's supposed to be a short and powerful response. Unfortunately, the body doesn't turn off the inflammation switch and it ends up destroying the very tissues and organs it was meant to protect. We tend to think of inflammation as synonymous with arthritis. However, inflammation can strike anywhere in your body. It's a major contributor to heart disease, cancer, Alzheimer's, and many more life-threatening conditions. Control inflammation and you control disease.
In her book, Prevent Cancer, Strokes, Heart Attacks and other Deadly Killers! Dr. Vijaya Nair, Harvard-trained M.D. FAMS, M.S. (Epid) says, "Inflammation is a double-edged sword. On the one hand, it protects you. When you get a splinter, inflammation makes sure that immune cells arrive at the scene of the injury to kill any bacteria or viruses that may have entered the broken skin. That's what all that redness, heat, swelling, and pain is about. Your immune system is going to war! On the other hand, inflammation can kill you. It can cause diseases no one wants to get, like cancer, arthritis, heart disease, digestive tract diseases, macular degeneration, Alzheimer's disease, and chronic fatigue syndrome."
Inflammation is only supposed to stick around as long as a threat exists. That's why your inflammation levels shoot through the roof if you have a severe bacterial infection, but, quickly go back to normal once the bacteria is successfully eliminated. When the body doesn't turn off the inflammation response -- when all those inflammatory chemicals stay in the system for a long time -- it ends up destroying.....read the whole article
To learm more about dementia, click here
Are you interested in dementia activities? Here is a good place to start
Inflammation is your immune system's way of protecting you from physical trauma or foreign invaders, such as viruses and bacteria. It's supposed to be a short and powerful response. Unfortunately, the body doesn't turn off the inflammation switch and it ends up destroying the very tissues and organs it was meant to protect. We tend to think of inflammation as synonymous with arthritis. However, inflammation can strike anywhere in your body. It's a major contributor to heart disease, cancer, Alzheimer's, and many more life-threatening conditions. Control inflammation and you control disease.
In her book, Prevent Cancer, Strokes, Heart Attacks and other Deadly Killers! Dr. Vijaya Nair, Harvard-trained M.D. FAMS, M.S. (Epid) says, "Inflammation is a double-edged sword. On the one hand, it protects you. When you get a splinter, inflammation makes sure that immune cells arrive at the scene of the injury to kill any bacteria or viruses that may have entered the broken skin. That's what all that redness, heat, swelling, and pain is about. Your immune system is going to war! On the other hand, inflammation can kill you. It can cause diseases no one wants to get, like cancer, arthritis, heart disease, digestive tract diseases, macular degeneration, Alzheimer's disease, and chronic fatigue syndrome."
Inflammation is only supposed to stick around as long as a threat exists. That's why your inflammation levels shoot through the roof if you have a severe bacterial infection, but, quickly go back to normal once the bacteria is successfully eliminated. When the body doesn't turn off the inflammation response -- when all those inflammatory chemicals stay in the system for a long time -- it ends up destroying.....read the whole article
To learm more about dementia, click here
Are you interested in dementia activities? Here is a good place to start
Saturday, January 3, 2009
Alzheimer's gene 'linked to Vitamin D'
Telegraph.com
Scientists have found a new Alzheimer's gene they believe could affect how our bodies use a vital vitamin.
By Kate Devlin, Medical Correspondent
Researchers hope that the breakthrough could one day lead to new treatments for the devastating neurological condition.
They believe that the gene could be connected to how the brain uses vitamin D, a lack of which has been linked to memory problems.
Scientists have previously found that the onset of the devastating condition was linked to the apolipoprotein E gene.
However, this is a "weak" gene, whose influence would not be enough to cause the illness.
The study looked at the genes of 492 patients who suffered from Alzheimer's disease and compared these to genes from 498 people who did not have the condition.
The analysis was detailed enough to identify single variants within DNA cells which are more common in patients with Alzheimer's.
The variation is close to the gene which uses vitamin D in the brain and has previously been linked to memory, the findings, published in the American Journal of Human Genetics, show.
"It is possible that (this variation) is in a region that may play some sort of regulatory role (with......read the whole story
For more Alzheimer's disease and dementia information,click here
For Alzheimer's disease and dementia activities, click here
Scientists have found a new Alzheimer's gene they believe could affect how our bodies use a vital vitamin.
By Kate Devlin, Medical Correspondent
Researchers hope that the breakthrough could one day lead to new treatments for the devastating neurological condition.
They believe that the gene could be connected to how the brain uses vitamin D, a lack of which has been linked to memory problems.
Scientists have previously found that the onset of the devastating condition was linked to the apolipoprotein E gene.
However, this is a "weak" gene, whose influence would not be enough to cause the illness.
The study looked at the genes of 492 patients who suffered from Alzheimer's disease and compared these to genes from 498 people who did not have the condition.
The analysis was detailed enough to identify single variants within DNA cells which are more common in patients with Alzheimer's.
The variation is close to the gene which uses vitamin D in the brain and has previously been linked to memory, the findings, published in the American Journal of Human Genetics, show.
"It is possible that (this variation) is in a region that may play some sort of regulatory role (with......read the whole story
For more Alzheimer's disease and dementia information,click here
For Alzheimer's disease and dementia activities, click here
Friday, January 2, 2009
Ground-breaking anti-amnesic and neuroprotective effects of Alzheimer's compound ANAVEX 1-41 published in Journal of Neuropsychopharmacology
ATHENS, GREECE,PRNewswire-FirstCall/ - Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL), a biopharmaceutical company engaged in the discovery and development of novel therapeutics to treat Central Nervous System (CNS) diseases and cancer, announces that the anti-amnesic and neuroprotective effects of ANAVEX 1-41 are detailed in a paper published in the current edition of Neuropsychopharmacology. Currently in the late pre-clinical stage, ANAVEX 1-41 is one of the company's lead compounds for Alzheimer's disease (AD). Neuropsychopharmacology is an international scientific journal and the official publication of the American College of Neuropsychopharmacology, which focuses on clinical and basic science contributions that advance our understanding of the brain and behaviour.
"The ANAVEX 1-41 results highlighted in this important paper clearly demonstrate the compound's efficacy, which can be attained at extremely.......read the whole article
For more information on dementia, click here
If you are interested in dementia activities, click here
"The ANAVEX 1-41 results highlighted in this important paper clearly demonstrate the compound's efficacy, which can be attained at extremely.......read the whole article
For more information on dementia, click here
If you are interested in dementia activities, click here
Subscribe to:
Posts (Atom)

